{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T19:14:17Z","timestamp":1773515657689,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2013,5,31]],"date-time":"2013-05-31T00:00:00Z","timestamp":1369958400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1038\/npp.2013.139","type":"journal-article","created":{"date-parts":[[2013,5,31]],"date-time":"2013-05-31T09:57:36Z","timestamp":1369994256000},"page":"2401-2408","source":"Crossref","is-referenced-by-count":34,"title":["Quantitative Electroencephalography Within Sleep\/Wake States Differentiates GABAA Modulators Eszopiclone and Zolpidem From Dual Orexin Receptor Antagonists in Rats"],"prefix":"10.1038","volume":"38","author":[{"given":"Steven V","family":"Fox","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony L","family":"Gotter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Spencer J","family":"Tye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan L","family":"Garson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan T","family":"Savitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason M","family":"Uslaner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph I","family":"Brunner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela L","family":"Tannenbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terrence P","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Hodgson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lihang","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark R","family":"Bowlby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott D","family":"Kuduk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul J","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Hargreaves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher J","family":"Winrow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John J","family":"Renger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,5,31]]},"reference":[{"key":"BFnpp2013139_CR1","first-page":"203","volume":"6","author":"P Achermann","year":"1987","unstructured":"Achermann P, Borbely AA (1987). Dynamics of EEG slow wave activity during physiological sleep and after administration of benzodiazepine hypnotics. Hum Neurobiol 6: 203\u2013210.","journal-title":"Hum Neurobiol"},{"key":"BFnpp2013139_CR2","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/sj.npp.1380110","volume":"11","author":"D Aeschbach","year":"1994","unstructured":"Aeschbach D, Dijk DJ, Trachsel L, Brunner DP, Borbely AA (1994). Dynamics of slow-wave activity and spindle frequency activity in the human sleep EEG: effect of midazolam and zopiclone. Neuropsychopharmacology 11: 237\u2013244.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2013139_CR3","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1038\/npp.2011.310","volume":"37","author":"P Bettica","year":"2012","unstructured":"Bettica P, Squassante L, Groeger JA, Gennery B, Winsky-Sommerer R, Dijk DJ (2012a). Differential effects of a dual orexin receptor antagonist (SB-649868) and zolpidem on sleep initiation and consolidation, SWS, REM sleep, and EEG power spectra in a model of situational insomnia. Neuropsychopharmacology 37: 1224\u20131233.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2013139_CR4","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1038\/npp.2011.310","volume":"37","author":"P Bettica","year":"2012","unstructured":"Bettica P, Squassante L, Groeger JA, Gennery B, Winsky-Sommerer R, Dijk DJ (2012b). Differential effects of a dual orexin receptor antagonist (SB-649868) and zolpidem on sleep initiation and consolidation, SWS, REM sleep, and EEG power spectra in a model of situational insomnia. Neuropsychopharmacology 37: 1224\u20131233.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2013139_CR5","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/nm1544","volume":"13","author":"C Brisbare-Roch","year":"2007","unstructured":"Brisbare-Roch C, Dingemanse J, Koberstein R, Hoever P, Aissaoui H, Flores S et al (2007). Promotion of sleep by targeting the orexin system in rats, dogs and humans. Nat Med 13: 150\u2013155.","journal-title":"Nat Med"},{"key":"BFnpp2013139_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF02244546","volume":"104","author":"DP Brunner","year":"1991","unstructured":"Brunner DP, Dijk DJ, Munch M, Borbely AA (1991). Effect of zolpidem on sleep and sleep EEG spectra in healthy young men. Psychopharmacology (Berl) 104: 1\u20135.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp2013139_CR7","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1002\/cmdc.201200025","volume":"7","author":"PJ Coleman","year":"2012","unstructured":"Coleman PJ, Schreier JD, Cox CD, Breslin MJ, Whitman DB, Bogusky MJ et al (2012). Discovery of [(2R,5R)-5-{[(5-fluoropyridin-2-yl)oxy]methyl}-2-methylpiperidin-1-yl][5-methyl-2-(pyrimidin-2-yl)phenyl]methanone (MK-6096): a dual orexin receptor antagonist with potent sleep-promoting properties. Chem Med Chem 7: 415\u2013424 337.","journal-title":"Chem Med Chem"},{"key":"BFnpp2013139_CR8","doi-asserted-by":"publisher","first-page":"5320","DOI":"10.1021\/jm100541c","volume":"53","author":"CD Cox","year":"2010","unstructured":"Cox CD, Breslin MJ, Whitman DB, Schreier JD, McGaughey GB, Bogusky MJ et al (2010). Discovery of the dual orexin receptor antagonist [(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone (MK-4305) for the treatment of insomnia. J Med Chem 53: 5320\u20135332.","journal-title":"J Med Chem"},{"key":"BFnpp2013139_CR9","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1093\/sleep\/27.5.851","volume":"27","author":"F Desarnaud","year":"2004","unstructured":"Desarnaud F, Murillo-Rodriguez E, Lin L, Xu M, Gerashchenko D, Shiromani SN et al (2004). The diurnal rhythm of hypocretin in young and old F344 rats. Sleep 27: 851\u2013856.","journal-title":"Sleep"},{"key":"BFnpp2013139_CR10","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/S1388-2457(00)00249-2","volume":"111","author":"F Espa","year":"2000","unstructured":"Espa F, Ondze B, Deglise P, Billiard M, Besset A (2000). Sleep architecture, slow wave activity, and sleep spindles in adult patients with sleepwalking and sleep terrors. Clin Neurophysiol 111: 929\u2013939.","journal-title":"Clin Neurophysiol"},{"key":"BFnpp2013139_CR11","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1016\/S1388-2457(99)00147-9","volume":"110","author":"B Feige","year":"1999","unstructured":"Feige B, Voderholzer U, Riemann D, Hohagen F, Berger M (1999). Independent sleep EEG slow-wave and spindle band dynamics associated with 4 weeks of continuous application of short-half-life hypnotics in healthy subjects. Clin Neurophysiol 110: 1965\u20131974.","journal-title":"Clin Neurophysiol"},{"key":"BFnpp2013139_CR12","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1124\/pr.111.005546","volume":"64","author":"AL Gotter","year":"2012","unstructured":"Gotter AL, Webber AL, Coleman PJ, Renger JJ, Winrow CJ (2012). International Union of Basic and Clinical Pharmacology. LXXXVI. Orexin receptor function, nomenclature and pharmacology. Pharmacol Rev 64: 389\u2013420.","journal-title":"Pharmacol Rev"},{"key":"BFnpp2013139_CR13","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1212\/WNL.0b013e31827688ee","volume":"79","author":"WJ Herring","year":"2012","unstructured":"Herring WJ, Snyder E, Budd K, Hutzelmann J, Snavely D, Liu K et al (2012). Orexin receptor antagonism for treatment of insomnia: a randomized clinical trial of suvorexant. Neurology 79: 2265\u20132274.","journal-title":"Neurology"},{"key":"BFnpp2013139_CR14","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1111\/j.1365-2125.2006.02705.x","volume":"62","author":"I Hindmarch","year":"2006","unstructured":"Hindmarch I, Legangneux E, Stanley N, Emegbo S, Dawson J (2006). A double-blind, placebo-controlled investigation of the residual psychomotor and cognitive effects of zolpidem-MR in healthy elderly volunteers. Br J Clin Pharmacol 62: 538\u2013545.","journal-title":"Br J Clin Pharmacol"},{"key":"BFnpp2013139_CR15","doi-asserted-by":"crossref","first-page":"471","DOI":"10.5664\/jcsm.27605","volume":"5","author":"R Hoque","year":"2009","unstructured":"Hoque R, Chesson AL Jr (2009). Zolpidem-induced sleepwalking, sleep related eating disorder, and sleep-driving: fluorine-18-flourodeoxyglucose positron emission tomography analysis, and a literature review of other unexpected clinical effects of zolpidem. J Clin Sleep Med 5: 471\u2013476.","journal-title":"J Clin Sleep Med"},{"key":"BFnpp2013139_CR16","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1126\/science.8036518","volume":"265","author":"A Karni","year":"1994","unstructured":"Karni A, Tanne D, Rubenstein BS, Askenasy JJ, Sagi D (1994). Dependence on REM sleep of overnight improvement of a perceptual skill. Science 265: 679\u2013682.","journal-title":"Science"},{"key":"BFnpp2013139_CR17","doi-asserted-by":"publisher","first-page":"5282","DOI":"10.1523\/JNEUROSCI.22-13-05282.2002","volume":"22","author":"LI Kiyashchenko","year":"2002","unstructured":"Kiyashchenko LI, Mileykovskiy BY, Maidment N, Lam HA, Wu MF, John J et al (2002). Release of hypocretin (orexin) during waking and sleep states. J Neurosci 22: 5282\u20135286.","journal-title":"J Neurosci"},{"key":"BFnpp2013139_CR18","first-page":"630","volume":"25","author":"AD Krystal","year":"2002","unstructured":"Krystal AD, Edinger JD, Wohlgemuth WK, Marsh GR (2002). NREM sleep EEG frequency spectral correlates of sleep complaints in primary insomnia subtypes. Sleep 25: 630\u2013640.","journal-title":"Sleep"},{"key":"BFnpp2013139_CR19","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1046\/j.1365-2869.2000.00192.x","volume":"9","author":"HP Landolt","year":"2000","unstructured":"Landolt HP, Finelli LA, Roth C, Buck A, Achermann P, Borbely AA (2000). Zolpidem and sleep deprivation: different effect on EEG power spectra. J Sleep Res 9: 175\u2013183.","journal-title":"J Sleep Res"},{"key":"BFnpp2013139_CR20","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1177\/0269881111424457","volume":"26","author":"J Lundahl","year":"2012","unstructured":"Lundahl J, Deacon S, Maurice D, Staner L (2012). EEG spectral power density profiles during NREM sleep for gaboxadol and zolpidem in patients with primary insomnia. J Psychopharmacol 26: 1081\u20131087.","journal-title":"J Psychopharmacol"},{"key":"BFnpp2013139_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0006-8993(02)03264-X","volume":"955","author":"GS Martinez","year":"2002","unstructured":"Martinez GS, Smale L, Nunez AA (2002). Diurnal and nocturnal rodents show rhythms in orexinergic neurons. Brain Res 955: 1\u20137.","journal-title":"Brain Res"},{"key":"BFnpp2013139_CR22","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1097\/00008877-199711000-00014","volume":"8","author":"MZ Mintzer","year":"1997","unstructured":"Mintzer MZ, Frey JM, Yingling JE, Griffiths RR (1997). Triazolam and zolpidem: a comparison of their psychomotor, cognitive, and subjective effects in healthy volunteers. Behav Pharmacol 8: 561\u2013574.","journal-title":"Behav Pharmacol"},{"key":"BFnpp2013139_CR23","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1053\/smrv.2002.0186","volume":"6","author":"MM Ohayon","year":"2002","unstructured":"Ohayon MM (2002). Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev 6: 97\u2013111.","journal-title":"Sleep Med Rev"},{"key":"BFnpp2013139_CR24","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1002\/hup.980","volume":"23","author":"S Otmani","year":"2008","unstructured":"Otmani S, Demazieres A, Staner C, Jacob N, Nir T, Zisapel N et al (2008). Effects of prolonged-release melatonin, zolpidem, and their combination on psychomotor functions, memory recall, and driving skills in healthy middle aged and elderly volunteers. Hum Psychopharmacol 23: 693\u2013705.","journal-title":"Hum Psychopharmacol"},{"key":"BFnpp2013139_CR25","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.brainres.2004.02.067","volume":"1010","author":"JJ Renger","year":"2004","unstructured":"Renger JJ, Dunn SL, Motzel SL, Johnson C, Koblan KS (2004). Sub-chronic administration of zolpidem affects modifications to rat sleep architecture. Brain Res 1010: 45\u201354.","journal-title":"Brain Res"},{"key":"BFnpp2013139_CR26","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1097\/00004714-199804000-00008","volume":"18","author":"CR Rush","year":"1998","unstructured":"Rush CR, Armstrong DL, Ali JA, Pazzaglia PJ (1998). Benzodiazepine-receptor ligands in humans: acute performance-impairing, subject-rated and observer-rated effects. J Clin Psychopharmacol 18: 154\u2013165.","journal-title":"J Clin Psychopharmacol"},{"key":"BFnpp2013139_CR27","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1038\/nature04284","volume":"437","author":"CB Saper","year":"2005","unstructured":"Saper CB, Scammell TE, Lu J (2005). Hypothalamic regulation of sleep and circadian rhythms. Nature 437: 1257\u20131263.","journal-title":"Nature"},{"key":"BFnpp2013139_CR28","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1101\/lm.74904","volume":"11","author":"CT Smith","year":"2004","unstructured":"Smith CT, Nixon MR, Nader RS (2004). Posttraining increases in REM sleep intensity implicate REM sleep in memory processing and provide a biological marker of learning potential. Learn Mem 11: 714\u2013719.","journal-title":"Learn Mem"},{"key":"BFnpp2013139_CR29","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.biopsycho.2012.08.009","volume":"91","author":"K Spiegelhalder","year":"2012","unstructured":"Spiegelhalder K, Regen W, Feige B, Holz J, Piosczyk H, Baglioni C et al (2012). Increased EEG sigma and beta power during NREM sleep in primary insomnia. Biol Psychol 91: 329\u2013333.","journal-title":"Biol Psychol"},{"key":"BFnpp2013139_CR30","first-page":"11","volume":"3","author":"L Trachsel","year":"1990","unstructured":"Trachsel L, Dijk DJ, Brunner DP, Klene C, Borbely AA (1990). Effect of zopiclone and midazolam on sleep and EEG spectra in a phase-advanced sleep schedule. Neuropsychopharmacology 3: 11\u201318.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2013139_CR31","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3109\/01677063.2011.566953","volume":"25","author":"CJ Winrow","year":"2011","unstructured":"Winrow CJ, Gotter AL, Cox CD, Doran SM, Tannenbaum PL, Breslin MJ et al (2011). Promotion of sleep by suvorexant\u2014a novel dual orexin receptor antagonist. J Neurogenet 25: 52\u201361.","journal-title":"J Neurogenet"},{"key":"BFnpp2013139_CR32","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.neuropharm.2011.10.003","volume":"62","author":"CJ Winrow","year":"2012","unstructured":"Winrow CJ, Gotter AL, Cox CD, Tannenbaum PL, Garson SL, Doran SM et al (2012). Pharmacological characterization of MK-6096\u2014a dual orexin receptor antagonist for insomnia. Neuropharmacology 62: 978\u2013987.","journal-title":"Neuropharmacology"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/npp2013139.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp2013139","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp2013139.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T23:44:44Z","timestamp":1684453484000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/npp2013139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,31]]},"references-count":32,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["BFnpp2013139"],"URL":"https:\/\/doi.org\/10.1038\/npp.2013.139","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,31]]}}}